Wichgers Schreur Paul J, Paweska Janusz T, Kant Jet, Kortekaas Jeroen
Wageningen Bioveterinary Research, Department of Virology, Lelystad, The Netherlands.
National Institute for Communicable Diseases of the National Health Laboratory Service, Center for Emerging and Zoonotic Diseases, Sandringham 2131, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.
J Virol Methods. 2017 Oct;248:26-30. doi: 10.1016/j.jviromet.2017.06.001. Epub 2017 Jun 3.
Antibodies specific for Rift Valley fever virus (RVFV) can be detected by diverse methods, including ezyme-linked immunosortbent assay (ELISA) and virus neutralization test (VNT). The VNT is superior in sensitivity and specificity and is therefore considered the gold standard serological assay. Classical VNTs make use of virulent RVFV and therefore have to be performed in biosafety level 3 laboratories. Here, we report the development of a novel VNT that is based on an avirulent RVFV expressing the enhanced green fluorescent protein (eGFP), which can be performed safely outside level 3 biocontainment facilities. Evaluation with a broad panel of experimental sera and field sera demonstrated that this novel VNT is faster and more sensitive than the classical VNT.
可通过多种方法检测裂谷热病毒(RVFV)特异性抗体,包括酶联免疫吸附测定(ELISA)和病毒中和试验(VNT)。VNT在灵敏度和特异性方面更具优势,因此被视为血清学检测的金标准。传统的VNT使用强毒力的RVFV,因此必须在生物安全3级实验室进行。在此,我们报告了一种新型VNT的开发,该方法基于表达增强型绿色荧光蛋白(eGFP)的无毒力RVFV,可在3级生物安全防护设施外安全进行。对大量实验血清和现场血清的评估表明,这种新型VNT比传统VNT更快、更灵敏